CellSeed Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Revenue	161	199	275	1,026	85
Revenue Growth (YoY)	-19.10%	-27.64%	-73.20%	1107.06%	-15.00%
Cost of Revenue	98	78	87	63	83
Gross Profit	63	121	188	963	2
Selling, General & Admin	387	402	423	391	394
Research & Development	541	438	546	432	632
Operating Expenses	928	840	969	823	1,026
Operating Income	-865	-719	-781	140	-1,024
Earnings From Equity Investments	-20	-14	-	-	-
Currency Exchange Gain (Loss)	1	-	-	-	-
Other Non Operating Income (Expenses)	-3	-11	-4	-1	60
EBT Excluding Unusual Items	-887	-744	-785	139	-964
Asset Writedown	-25	-37	-	-	-
Other Unusual Items	1	1	3	-	-
Pretax Income	-911	-780	-782	139	-964
Income Tax Expense	3	3	-	10	2
Net Income	-914	-783	-782	129	-966
Net Income to Common	-914	-783	-782	129	-966
Shares Outstanding (Basic)	17	14	12	11	10
Shares Outstanding (Diluted)	17	14	12	12	10
Shares Change (YoY)	21.34%	20.64%	2.02%	11.17%	13.50%
EPS (Basic)	-53.15	-55.25	-66.56	11.29	-93.25
EPS (Diluted)	-53.15	-55.25	-66.56	11.27	-93.25
Free Cash Flow	-908	-707	-590	-307	-752
Free Cash Flow Per Share	-52.80	-49.88	-50.22	-26.66	-72.59
Gross Margin	39.13%	60.80%	68.36%	93.86%	2.35%
Operating Margin	-537.27%	-361.31%	-284.00%	13.64%	-1204.71%
Profit Margin	-567.70%	-393.47%	-284.36%	12.57%	-1136.47%
Free Cash Flow Margin	-563.98%	-355.28%	-214.54%	-29.92%	-884.71%
EBITDA	-863	-710	-776	144	-1,020
EBITDA Margin	-	-	-282.18%	14.04%	-
D&A For EBITDA	2	9	5	4	4
EBIT	-865	-719	-781	140	-1,024
EBIT Margin	-	-	-284.00%	13.64%	-
Effective Tax Rate	-	-	-	7.19%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.